Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial.

MLA

Oh, Do-Youn, et al. “Bintrafusp Alfa and Chemotherapy as First-Line Treatment in Biliary Tract Cancer: A Randomized Phase 2/3 Trial.” Hepatology (Baltimore, Md.), June 2024. EBSCOhost, https://doi.org/10.1097/HEP.0000000000000965.

APA

Oh, D.-Y., Ikeda, M., Lee, C.-K., Rojas, C., Hsu, C.-H., Kim, J. W., Shen, L., Furuse, J., Park, J. O., Borad, M., de Braud, F., Bridgewater, J., Lee, S. S., Moehler, M., Audhuy, F., Osada, M., Sato, M., & Yoo, C. (2024). Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial. Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000000965

Chicago

Oh, Do-Youn, Masafumi Ikeda, Choong-Kun Lee, Carlos Rojas, Chih-Hung Hsu, Jin Won Kim, Lin Shen, et al. 2024. “Bintrafusp Alfa and Chemotherapy as First-Line Treatment in Biliary Tract Cancer: A Randomized Phase 2/3 Trial.” Hepatology (Baltimore, Md.), June. doi:10.1097/HEP.0000000000000965.